To examine the response to chronic high-dose angiotensin II (Ang II) and a proposed milder response in female hearts with respect to gene expression and ischemic injury. Female and male litter–matched rats were treated with 400 ng kg-1 min-1 Ang II for 14 days. Hearts were isolated, subjected to 30-min ischemia and 30-min reperfusion in combination with functional monitoring and thereafter harvested for gene expression, WB and histology. Ang II-treated hearts showed signs of non-hypertrophic remodeling and had significantly higher end diastolic pressure after reperfusion, but no significant gender difference was detected. Ang II increased expression of genes related to heart function (ANF, β-MCH, Ankrd-1, PKC-α, PKC-δ T...
The response to ischemia/reperfusion and the effects of ischemic post-conditioning (IPC) are sex-dep...
Background: Cardiac hypertrophy is the most potent cardiovascular risk factor after age, and relativ...
Transforming growth factor beta ligands and receptors are known to be pro-hypertrophic and pro-fibro...
To examine the response to chronic high-dose angiotensin II (Ang II) and a proposed milder response ...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Objective: Female gender is associated with reduced tolerance against acute ischemic events and a hi...
Objective: Female gender is associated with reduced tolerance against acute ischemic events and a hi...
Objective: Female gender is associated with reduced tolerance against acute ischemic events and a hi...
Background: Cardiac hypertrophy is the most potent cardiovascular risk factor after age, and relativ...
The aim of this study was to investigate both the effects of chronic treatment with atrial natriuret...
The response to ischemia/reperfusion and the effects of ischemic post-conditioning (IPC) are sex-dep...
Background: Cardiac hypertrophy is the most potent cardiovascular risk factor after age, and relativ...
Transforming growth factor beta ligands and receptors are known to be pro-hypertrophic and pro-fibro...
To examine the response to chronic high-dose angiotensin II (Ang II) and a proposed milder response ...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Angiotensin-converting enzyme 2 (ACE 2) in the heart including its sex dependency in the hypertensiv...
Objective: Female gender is associated with reduced tolerance against acute ischemic events and a hi...
Objective: Female gender is associated with reduced tolerance against acute ischemic events and a hi...
Objective: Female gender is associated with reduced tolerance against acute ischemic events and a hi...
Background: Cardiac hypertrophy is the most potent cardiovascular risk factor after age, and relativ...
The aim of this study was to investigate both the effects of chronic treatment with atrial natriuret...
The response to ischemia/reperfusion and the effects of ischemic post-conditioning (IPC) are sex-dep...
Background: Cardiac hypertrophy is the most potent cardiovascular risk factor after age, and relativ...
Transforming growth factor beta ligands and receptors are known to be pro-hypertrophic and pro-fibro...